RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Linc
L

Linc portfolio

Linc has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $28M.
Latest deal: Gesynta Pharma · Jan 24, 2025.
About this page

Its most recent investment on record is Gesynta Pharma's $28M Series B+ round in January 2025, alongside Industrifonden, Catalyze Capital, Hadean Ventures and 4 others. That company is in Health and bio.

What Linc invests in

How Linc invests

StageDealsCapital in rounds
Series B+ 1 100%$28M

Linc portfolio companies

CompanyRound with LincTotal raisedLatest raise
GGesynta Pharma
Health and bio
Series B+ · $28M$28MJul 23, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Linc. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Linc, which is a subset of its real portfolio. API: /api/v1/investors/linc (get a free API key). More: the most active VC firms and new venture capital funds.